Stetz Gary S.'s Form 4 filing
Hepion Pharmaceuticals, Inc. (HEPA) · filed Apr 27, 2026
- Accession no.
- 0001493152-26-019027
- Filed
- Apr 27, 2026, 6:24 AM ET
- Trade date
- Apr 21, 2026
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $50.0K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stetz Gary S.CIK 0001532793 | Director, Officer (Interim CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +1,250,000 | $0.04 | +$50,000 | 1,250,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.